ArticleCureus2025
A Case of Cryptococcal Meningitis in an Immunocompetent Individual.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cryptococcal meningitis is classically associated with immunocompromised hosts but can also occur in individuals without identifiable immune dysfunction. Its nonspecific and often indolent presentation may delay diagnosis, particularly when early neuroimaging suggests alternative etiologies. We report a case of a 49-year-old immunocompetent man who presented with progressive headaches, sensory changes such as transient hearing loss, visual changes, and balance issues. Initial imaging showed a hyperdense area on CT, which was interpreted as a possible cerebrovascular accident, delaying recognition of an infectious process. Cerebrospinal fluid (CSF) evaluation ultimately confirmed cryptococcal meningitis, and the patient improved with targeted antifungal therapy and intracranial pressure (ICP)-directed management. This case highlights diagnostic challenges in immunocompetent hosts and underscores the importance of maintaining suspicion for fungal meningitis even without classic risk factors.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.